Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02CFR
|
||||
Former ID |
DIB006237
|
||||
Drug Name |
GW-559768X
|
||||
Synonyms |
GW-559768X; GW-569998X; GW-578257A; GW-585550A; RET tyrosine kinase inhibitors (cancer); RET tyrosine kinase inhibitors (cancer), GlaxoSmithKline
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543572] | ||
Company |
GlaxoSmithKline plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
O=S(=O)(c1ccc2c(c1)c(ccn2)Nc1c(cc(c(c1)O)F)O)C
|
||||
Target and Pathway | |||||
Target(s) | Proto-oncogene tyrosine-protein kinase receptor ret | Target Info | Inhibitor | [543572] | |
WikiPathways | SIDS Susceptibility Pathways | ||||
Dopaminergic Neurogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.